The role of genetic factors in the development of hyperhomocysteinemia

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 11, 2003, Pages 1427-1434

  Geisel, Jürgen ^a   Hübner, Ulrich ^a   Bodis, Marion ^a   Schorr, Heike ^a   Knapp, Jean Pierre ^a   Obeid, Rima ^a   Herrmann, Wolfgang ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Genetics; Homocsyteine; Polymorphism; Vegetarians

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CATECHOL METHYLTRANSFERASE; CYANOCOBALAMIN; FOLIC ACID; GLYCINE HYDROXYMETHYLTRANSFERASE; HOMOCYSTEINE; METHYLMALONIC ACID; THYMIDYLATE SYNTHASE; TRANSCOBALAMIN; TRANSCOBALAMIN II;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; AMINO ACID SUBSTITUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DISEASE SEVERITY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; VEGETARIAN DIET; VITAMIN METABOLISM;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); AGED; AGED, 80 AND OVER; AGING; CATECHOL O-METHYLTRANSFERASE; DIET, VEGETARIAN; FOLIC ACID DEFICIENCY; GENOTYPE; GLYCINE HYDROXYMETHYLTRANSFERASE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MIDDLE AGED; MUTATION; THYMIDYLATE SYNTHASE; TRANSCOBALAMINS; VITAMIN B 12 DEFICIENCY;

EID: 0345169186     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.219     Document Type: Review

References (29)

1. Lievers KJ, Kluijtmans LA, Blom HJ. Genetics of hyperhomocysteinaemia in cardiovascular disease. Ann Clin Biochem 2003; 40:46-59.
2. Geisel J, Zimbelmann I, Schorr H, Knapp JP, Bodis M, Hübner U, et al. Genetic defects as important factors for moderate hyperhomocysteinemia. Clin Chem Lab Med 2001; 39:698-704.
3. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999; 19:217-46.
4. Herrmann W. The importance of hyperhomocysteinemia as a risk factor for diseases: an overview. Clin Chem Lab Med 2001; 39:666-74.
5. Heil SG, Lievers KJ, Boers GH, Verhoef P, den Heijer M, Trijbels FJ, et al. Betaine-homocysteine methyltransferase (BHMT): genomic sequencing and relevance to hyperhomocysteinemia and vascular disease in humans. Mol Genet Metab 2000; 71:511-9.
6. Zhu BT. Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr Drug Metab 2002; 3:321-49.
7. Devlin AM, Ling EH, Peerson JM, Fernando S, Clarke R, Smith AD, et al. Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum Mol Genet 2000; 9:2837-44.
8. Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, et al. A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 2000; 70:310-5.
9. Seetharam B, Li N. Transcobalamin II and its cell surface receptor. Vitam Horm 2000; 59:337-66.
10. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase [letter]. Nat Genet 1995; 10:111-3.
11. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6:243-50.
12. Kawakami K, Omura K, Kanehira E, Watanabe Y. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res 1999; 19:3249-52.
13. Heil SG, Van Der Put NM, Waas ET, den Heijer M, Trijbels FJ, Blom HJ. Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab 2001; 73:164-72.
14. Namour F, Olivier J, Abdelmouttaleb I, Adjalla C, Debard R, Salvat C, et al. Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood. Blood 2001; 97:1092-8.
15. McCaddon A, Blennow K, Hudson P, Regland B, Hill D. Transcobalamin polymorphism and homocysteine. Blood 2001; 98:3497-9.
16. 12 status in healthy older adults. Blood 2002; 100:718-20.
17. Herrmann W, Quast S, Ullrich M, Schultze H, Bodis M, Geisel J. Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation. Atherosclerosis 1999; 144:91-101.
18. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Elevation of 2-methylcitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency. Metabolism 1993; 42:978-88.
19. Stabler SP, Lindenbaum J, Savage DG, Allen RH. Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood 1993; 81:3404-13.
20. DeMille MMC, Kidd JR, Ruggeri V, Palmatier MA, Goldmann D, Odunsi A, et al. Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding variation. Hum Genet 2002; 111:521-37.
21. Herrmann W, Obeid R, Schorr H, Zarzour W, Geisel J. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: a facet of nature-nurture interplay. Clin Chem Lab Med 2003; 41:547-53.
22. Strous RD, Bark N, Woerner M, Lachman HM. Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia. Biol Psychiatry 1997; 41:493-5.
23. Horie N, Aiba H, Oguro K, Hojo H, Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 1995; 20:191-7.
24. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 2002; 325:1202.
25. 12 status, particularly holotrans-cobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia. Am J Clin Nutr 2003; 78:131-6.
26. Tisman G, Herbert V. B 12 dependence of cell uptake of serum folate: an explanation for high serum folate and cell folate depletion in B 12 deficiency. Blood 1973; 41:465-9.
27. Lievers KJ, Afman LA, Kluijtmans LA, Boers GH, Verhoef P, den Heijer M, et al. Polymorphisms in the transcobalamin gene: association with plasma homocysteine in healthy individuals and vascular disease patients. Clin Chem 2002; 48:1383-9.
28. Noga AA, Stead LM, Zhao Y, Brosnan ME, Brosnan JT, Vance DE. Plasma homocysteine is regulated by phospho-lipid methylation. J Biol Chem 2003; 278:5952-5.
29. Muller T, Woitalla D, Fowler B, Kuhn W. 3-OMD and homocysteine plasma levels in parkinsonian patients. J Neural Transm 2002; 109:175-9.